Download PDF
Semin Liver Dis 2011; 31(1): 071-081
DOI: 10.1055/s-0031-1272834
© Thieme Medical Publishers

De Novo Autoimmune Hepatitis after Liver Transplantation

Maria Guido1 , Patrizia Burra2
  • 1Department of Medical Sciences and Special Therapies - Pathology Unit, University of Padova, Padova, Italy
  • 2Department of Gastroenterological and Surgical Sciences, University of Padova, Padova, Italy
Further Information

Publication History

Publication Date:
22 February 2011 (online)

    Permissions and Reprints

ABSTRACT

Allograft dysfunction with clinical, serologic, and histologic features resembling autoimmune hepatitis (AIH) may develop in pediatric and adult patients who have received a liver transplant (LT) for end-stage diseases other than AIH. This condition is now known as de novo AIH, although its pathophysiology is still uncertain and whether it represents a specific type of rejection or a genuine form of AIH is under debate. The occurrence of de novo AIH seems to be unrelated to the etiology of the disease necessitating liver transplantation, but it has been correlated with antiviral treatment in cases of hepatitis C virus (HCV) infection recurring after LT. Several investigators have reported adverse outcome of de novo AIH, including graft failure, particularly in cases with late diagnosis. Prompt treatment with prednisone, with or without azathioprine (in addition to the basic immunosuppressive regimen), seems to be the best option. The histology of de novo AIH is characterized by an infiltrate rich in plasma cells with significant interface hepatitis and perivenular necro-inflammatory activity. These features are not specific for autoimmune damage; therefore, other causes of graft dysfunction must be excluded. The final diagnosis may be a challenge in patients with recurrent hepatitis C, and requires careful clinical and pathologic assessment.

KEYWORDS

Autoimmune hepatitis - liver transplantation - histology

REFERENCES

  • 1 Kerkar N, Hadzić N, Davies E T et al.. De-novo autoimmune hepatitis after liver transplantation.  Lancet. 1998;  351 (9100) 409-413
    CrossrefPubMedGoogle Scholar
  • 2 Heneghan M A, Portmann B C, Norris S M et al.. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.  Hepatology. 2001;  34 (3) 464-470
    CrossrefPubMedGoogle Scholar
  • 3 Conti F, Dousset B, Levillayer H, Gruska I, Weill B, Calmus Y. Autoantibodies after liver transplantation: a marker of allograft disease.  J Hepatol. 1997;  26 (S1) 150A
    PubMedGoogle Scholar
  • 4 Jones D E, James O F, Portmann B, Burt A D, Williams R, Hudson M. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.  Hepatology. 1999;  30 (1) 53-57
    CrossrefPubMedGoogle Scholar
  • 5 Andries S, Casamayou L, Sempoux C et al.. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.  Transplantation. 2001;  72 (2) 267-272
    CrossrefPubMedGoogle Scholar
  • 6 Tan C K, Sian Ho J M. Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation.  Liver Transpl. 2001;  7 (5) 461-465
    CrossrefPubMedGoogle Scholar
  • 7 Spada M, Bertani A, Sonzogni A et al.. A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis.  Transplant Proc. 2001;  33 (1–2) 1747-1748
    CrossrefPubMedGoogle Scholar
  • 8 Gupta P, Hart J, Millis J M, Cronin D, Brady L. De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation.  Transplantation. 2001;  71 (5) 664-668
    CrossrefPubMedGoogle Scholar
  • 9 Hernandez H M, Kovarik P, Whitington P F, Alonso E M. Autoimmune hepatitis as a late complication of liver transplantation.  J Pediatr Gastroenterol Nutr. 2001;  32 (2) 131-136
    CrossrefPubMedGoogle Scholar
  • 10 Yoshizawa K, Shirakawa H, Ichijo T et al.. De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis.  Clin Transplant. 2008;  22 (3) 385-390
    CrossrefPubMedGoogle Scholar
  • 11 Oya H, Sato Y, Yamamoto S et al.. De novo autoimmune hepatitis after living donor liver transplantation in a 25-day-old newborn baby: a case report.  Transplant Proc. 2009;  41 (1) 433-434
    CrossrefPubMedGoogle Scholar
  • 12 Berardi S, Lodato F, Gramenzi A et al.. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?.  Gut. 2007;  56 (2) 237-242
    CrossrefPubMedGoogle Scholar
  • 13 Rifle G, Mousson C, Martin L, Guignier F, Hajji K. Donor-specific antibodies in allograft rejection: clinical and experimental data.  Transplantation. 2005;  79 (3, Suppl) S14-S18
    CrossrefPubMedGoogle Scholar
  • 14 Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation.  J Hepatol. 2004;  40 (1) 3-7
    PubMedGoogle Scholar
  • 15 Hübscher S G. Recurrent autoimmune hepatitis after liver transplantation: diagnostic criteria, risk factors, and outcome.  Liver Transpl. 2001;  7 (4) 285-291
    CrossrefPubMedGoogle Scholar
  • 16 Jones DEJ, James OFW, Portmann B, Burt A D, Williams R, Hudson M. Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.  Hepatology. 1999;  30 (1) 53-57
    CrossrefPubMedGoogle Scholar
  • 17 Czaja A J. Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance.  Liver Transpl. 2002;  8 (6) 505-513
    CrossrefPubMedGoogle Scholar
  • 18 Vanderlugt C L, Miller S D. Epitope spreading in immune-mediated diseases: implications for immunotherapy.  Nat Rev Immunol. 2002;  2 (2) 85-95
    CrossrefPubMedGoogle Scholar
  • 19 Aichele P, Bachmann M F, Hengartner H, Zinkernagel R M. Immunopathology or organ-specific autoimmunity as a consequence of virus infection.  Immunol Rev. 1996;  152 21-45
    CrossrefPubMedGoogle Scholar
  • 20 Oldstone MBA. Molecular mimicry and immune-mediated diseases.  FASEB J. 1998;  12 (13) 1255-1265
    PubMedGoogle Scholar
  • 21 Choudhuri K, Gregorio G V, Mieli-Vergani G, Vergani D. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.  Hepatology. 1998;  28 (5) 1177-1181
    CrossrefPubMedGoogle Scholar
  • 22 Zhao Z S, Granucci F, Yeh L, Schaffer P A, Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.  Science. 1998;  279 (5355) 1344-1347
    CrossrefPubMedGoogle Scholar
  • 23 Albert L J, Inman R D. Molecular mimicry and autoimmunity.  N Engl J Med. 1999;  341 (27) 2068-2074
    CrossrefPubMedGoogle Scholar
  • 24 Salcedo M, Vaquero J, Bañares R et al.. Response to steroids in de novo autoimmune hepatitis after liver transplantation.  Hepatology. 2002;  35 (2) 349-356
    CrossrefPubMedGoogle Scholar
  • 25 Bucy R P, Xu X Y, Li J, Huang G Q. Cyclosporin A-induced autoimmune disease in mice.  J Immunol. 1993;  151 (2) 1039-1050
    PubMedGoogle Scholar
  • 26 Glazier A, Tutschka P J, Farmer E R, Santos G W. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution.  J Exp Med. 1983;  158 (1) 1-8
    CrossrefPubMedGoogle Scholar
  • 27 Hess A D, Fischer A C. Immune mechanisms in cyclosporine-induced syngeneic graft-versus-host disease.  Transplantation. 1989;  48 (6) 895-900
    PubMedGoogle Scholar
  • 28 Hess A D, Horwitz L R, Laulis M K. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.  Transplant Proc. 1993;  25 (1 Pt 2) 1218-1221
    PubMedGoogle Scholar
  • 29 Hess A D, Horwitz L R, Laulis M K, Fuchs E. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens.  Clin Immunol Immunopathol. 1993;  69 (3) 341-350
    CrossrefPubMedGoogle Scholar
  • 30 Cooper M H, Hartman G G, Starzl T E, Fung J J. The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506.  Transplant Proc. 1991;  23 (6) 3234-3235
    PubMedGoogle Scholar
  • 31 Cholongitas E, Samonakis D, Patch D et al.. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus.  Transplantation. 2006;  81 (3) 488-490
    CrossrefPubMedGoogle Scholar
  • 32 Kontorinis N, Agarwal K, Elhajj N, Fiel M I, Schiano T D. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.  Liver Transpl. 2006;  12 (5) 827-830
    CrossrefPubMedGoogle Scholar
  • 33 Stanca C M, Fiel M I, Kontorinis N, Agarwal K, Emre S, Schiano T D. Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin.  Transplantation. 2007;  84 (2) 180-186
    CrossrefPubMedGoogle Scholar
  • 34 Fiel M I, Agarwal K, Stanca C et al.. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.  Liver Transpl. 2008;  14 (6) 861-871
    CrossrefPubMedGoogle Scholar
  • 35 Ward S C, Schiano T D, Thung S N, Fiel M I. Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant.  Liver Transpl. 2009;  15 (12) 1826-1833
    CrossrefPubMedGoogle Scholar
  • 36 Clifford B D, Donahue D, Smith L et al.. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.  Hepatology. 1995;  21 (3) 613-619
    CrossrefPubMedGoogle Scholar
  • 37 Muratori P, Muratori L, Stroffolini T et al.. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population.  Clin Exp Immunol. 2003;  131 (1) 118-121
    CrossrefPubMedGoogle Scholar
  • 38 Ferri S, Muratori L, Lenzi M, Granito A, Bianchi F B, Vergani D. HCV and autoimmunity.  Curr Pharm Des. 2008;  14 (17) 1678-1685
    CrossrefPubMedGoogle Scholar
  • 39 García-Buey L, García-Monzón C, Rodriguez S et al.. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C.  Gastroenterology. 1995;  108 (6) 1770-1777
    CrossrefPubMedGoogle Scholar
  • 40 Bayraktar Y, Bayraktar M, Gurakar A, Hassanein T I, Van Thiel D H. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.  Hepatogastroenterology. 1997;  44 (14) 417-425
    PubMedGoogle Scholar
  • 41 Noda K, Enomoto N, Arai K et al.. Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy.  Scand J Gastroenterol. 1996;  31 (7) 716-722
    CrossrefPubMedGoogle Scholar
  • 42 Pileri P, Uematsu Y, Campagnoli S et al.. Binding of hepatitis C virus to CD81.  Science. 1998;  282 (5390) 938-941
    CrossrefPubMedGoogle Scholar
  • 43 Stroffolini T, Colloredo G, Gaeta G B et al.. Does an ‘autoimmune’ profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey.  J Viral Hepat. 2004;  11 (3) 257-262
    CrossrefPubMedGoogle Scholar
  • 44 Narciso-Schiavon J L, Freire F C, Suarez M M et al.. Antinuclear antibody positivity in patients with chronic hepatitis C: clinically relevant or an epiphenomenon?.  Eur J Gastroenterol Hepatol. 2009;  21 (4) 440-446
    CrossrefPubMedGoogle Scholar
  • 45 Bianchi F B, Muratori P, Granito A, Pappas G, Ferri S, Muratori L. Hepatitis C and autoreactivity.  Dig Liver Dis. 2007;  39 (Suppl 1) S22-S24
    CrossrefPubMedGoogle Scholar
  • 46 Czaja A J, Carpenter H A. Histological findings in chronic hepatitis C with autoimmune features.  Hepatology. 1997;  26 (2) 459-466
    CrossrefPubMedGoogle Scholar
  • 47 Chrétien P, Chousterman M, Abd Alsamad I et al.. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.  J Autoimmun. 2009;  32 (3–4) 201-205
    CrossrefPubMedGoogle Scholar
  • 48 Khettry U, Huang W Y, Simpson M A et al.. Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.  Hum Pathol. 2007;  38 (3) 443-452
    CrossrefPubMedGoogle Scholar
  • 49 Czaja A J, Manns M P. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis.  Gastroenterology. 2010;  139 (1) 58-72, e4
    CrossrefPubMedGoogle Scholar
  • 50 Wiegard C, Schramm C, Lohse A W. Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future.  Semin Liver Dis. 2009;  29 (3) 254-261
    Article in Thieme ConnectPubMedGoogle Scholar
  • 51 Demetris A J, Adeyi O, Bellamy C O Banff Working Group et al. Liver biopsy interpretation for causes of late liver allograft dysfunction.  Hepatology. 2006;  44 (2) 489-501
    CrossrefPubMedGoogle Scholar
  • 52 Bogdanos D P, Mieli-Vergani G, Vergani D. Autoantibodies and their antigens in autoimmune hepatitis.  Semin Liver Dis. 2009;  29 (3) 241-253
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Aguilera I, Wichmann I, Sousa J M et al.. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation.  Clin Exp Immunol. 2001;  126 (3) 535-539
    CrossrefPubMedGoogle Scholar
  • 54 Aguilera I, Sousa J M, Gavilán F, Bernardos A, Wichmann I, Nuñez-Roldán A. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation.  Liver Transpl. 2004;  10 (9) 1166-1172
    CrossrefPubMedGoogle Scholar
  • 55 Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection.  Transplantation. 1998;  65 (8) 1072-1075
    CrossrefPubMedGoogle Scholar
  • 56 Duclos-Vallée J C, Johanet C, Bach J F, Yamamoto A M. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis.  J Hepatol. 2000;  33 (1) 163-166
    CrossrefPubMedGoogle Scholar
  • 57 Lohse A W, Obermayer-Straub P, Gerken G et al.. Development of cytochrome P450 2D6-specific LKM-autoantibodies following liver transplantation for Wilson's disease — possible association with a steroid-resistant transplant rejection episode.  J Hepatol. 1999;  31 (1) 149-155
    CrossrefPubMedGoogle Scholar
  • 58 Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H. High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection.  Transplantation. 1998;  65 (8) 1072-1075
    CrossrefPubMedGoogle Scholar
  • 59 Duclos-Vallée J C, Johanet C, Bach J F, Yamamoto A M. Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis.  J Hepatol. 2000;  33 (1) 163-166
    CrossrefPubMedGoogle Scholar
  • 60 Shinkura N, Ikai I, Egawa H et al.. Presence of anti-FKBP12 autoantibodies in patients with liver allografts: its association with allograft rejection.  Transplantation. 1997;  64 (9) 1336-1342
    CrossrefPubMedGoogle Scholar
  • 61 Salcedo M, Vaquero J, Banares R et al.. Serum autoantibodies after liver transplantation. Prevalence and associated immunologic disorders.  J Hepatol. 2003;  34 47A
    PubMedGoogle Scholar
  • 62 Evans H M, Kelly D A, McKiernan P J, Hübscher S. Progressive histological damage in liver allografts following pediatric liver transplantation.  Hepatology. 2006;  43 (5) 1109-1117
    CrossrefPubMedGoogle Scholar
  • 63 Avitzur Y, Ngan B Y, Lao M, Fecteau A, Ng V L. Prospective evaluation of the prevalence and clinical significance of positive autoantibodies after pediatric liver transplantation.  J Pediatr Gastroenterol Nutr. 2007;  45 (2) 222-227
    CrossrefPubMedGoogle Scholar
  • 64 Richter A, Grabhorn E, Helmke K, Manns M P, Ganschow R, Burdelski M. Clinical relevance of autoantibodies after pediatric liver transplantation.  Clin Transplant. 2007;  21 (3) 427-432
    CrossrefPubMedGoogle Scholar
  • 65 Riva S, Sonzogni A, Bravi M et al.. Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience.  Liver Transpl. 2006;  12 (4) 573-577
    CrossrefPubMedGoogle Scholar
  • 66 Hadzic N, Srinivasan R, Rela M et al.. De novo autoimmune hepatitis after liver transplantation in children; a single centre experience.  Hepatology. 2003;  38 202A
    PubMedGoogle Scholar
  • 67 Bogdanos D P, Invernizzi P, Mackay I R, Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges.  World J Gastroenterol. 2008;  14 (21) 3374-3387
    CrossrefPubMedGoogle Scholar
  • 68 Bach N, Thung S N, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis.  Hepatology. 1992;  15 (4) 572-577
    CrossrefPubMedGoogle Scholar
  • 69 Czaja A J, Carpenter H A. Autoimmune Hepatitis. In: McSween R NM, Burt A D, Portmann B C, Ishak K I, Scheuer P J, Anthony P P, eds. Pathology of the Liver. London: Churchill Livingstone; 2002: 415-434
    Google Scholar
  • 70 Hennes E M, Zeniya M, Czaja A J International Autoimmune Hepatitis Group et al. Simplified criteria for the diagnosis of autoimmune hepatitis.  Hepatology. 2008;  48 (1) 169-176
    CrossrefPubMedGoogle Scholar
  • 71 Misdraji J, Thiim M, Graeme-Cook F M. Autoimmune hepatitis with centrilobular necrosis.  Am J Surg Pathol. 2004;  28 (4) 471-478
    CrossrefPubMedGoogle Scholar
  • 72 Hofer H, Oesterreicher C, Wrba F, Ferenci P, Penner E. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation.  J Clin Pathol. 2006;  59 (3) 246-249
    CrossrefPubMedGoogle Scholar
  • 73 Zen Y, Notsumata K, Tanaka N, Nakanuma Y. Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis?.  Hum Pathol. 2007;  38 (11) 1669-1675
    CrossrefPubMedGoogle Scholar
  • 74 Demetris A J, Crawford J M, Minervini M I et al.. Transplantation pathology of the liver. In: Odze R D, Goldblum J R, eds. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. 2nd ed. Philadelphia: Saunders/Elsevier; 2009: 1177-1180
    Google Scholar
  • 75 Hubscher S GPB. Transplantation pathology. In: MacSween R NM, Burt A D, Ferrell L D, eds. Pathology of the Liver. 5th ed. London: Churchill Livingstone; 2007: 815-879
    Google Scholar
  • 76 Adeyi O, Fischer S E, Guindi M. Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation.  J Clin Pathol. 2010;  63 (1) 47-74
    CrossrefPubMedGoogle Scholar
  • 77 Czaja A J, Carpenter H A. Autoimmune hepatitis with incidental histologic features of bile duct injury.  Hepatology. 2001;  34 (4 Pt 1) 659-665
    CrossrefPubMedGoogle Scholar
  • 78 Krasinskas A M, Ruchelli E D, Rand E B, Chittams J L, Furth E E. Central venulitis in pediatric liver allografts.  Hepatology. 2001;  33 (5) 1141-1147
    CrossrefPubMedGoogle Scholar
  • 79 Nakazawa Y, Walker N I, Kerlin P et al.. Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: a comparative study in 54 patients.  Transplantation. 2000;  69 (8) 1599-1608
    PubMedGoogle Scholar
  • 80 Tsamandas A C, Jain A B, Felekouras E S, Fung J J, Demetris A J, Lee R G. Central venulitis in the allograft liver: a clinicopathologic study.  Transplantation. 1997;  64 (2) 252-257
    CrossrefPubMedGoogle Scholar
  • 81 Ludwig J, Gross Jr J B, Perkins J D, Moore S B. Persistent centrilobular necroses in hepatic allografts.  Hum Pathol. 1990;  21 (6) 656-661
    CrossrefPubMedGoogle Scholar
  • 82 Turlin B, Slapak G I, Hayllar K M, Heaton N, Williams R, Portmann B. Centrilobular necrosis after orthotopic liver transplantation: a longitudinal clinicopathologic study in 71 patients.  Liver Transpl Surg. 1995;  1 (5) 285-289
    CrossrefPubMedGoogle Scholar
  • 83 Demetris A J. Central venulitis in liver allografts: considerations of differential diagnosis.  Hepatology. 2001;  33 (5) 1329-1330
    CrossrefPubMedGoogle Scholar
  • 84 Demetris A J, Eghtesad B, Marcos A et al.. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.  Am J Surg Pathol. 2004;  28 (5) 658-669
    CrossrefPubMedGoogle Scholar
  • 85 Ziarkiewicz-Wróblewska B, Wróblewski T, Wasiutyński A. Morphological features and differential diagnosis of hepatitis C recurrence after liver transplantation - literature review and results of single transplantation center.  Ann Transplant. 2008;  13 (2) 12-20
    PubMedGoogle Scholar
  • 86 Manns M P, Czaja A J, Gorham J D American Association for the Study of Liver Diseases et al. Diagnosis and management of autoimmune hepatitis.  Hepatology. 2010;  51 (6) 2193-2213
    CrossrefPubMedGoogle Scholar

Maria GuidoM.D. 

Istituto di Anatomia Patologica

Via Gabelli, 61, 35100 Padova

Email: mguido@unipd.it

      >